頭孢他啶治療產(chǎn)婦產(chǎn)褥期感染的療效與安全性研究

打開文本圖片集

【摘要】目的：探討頭孢他啶治療產(chǎn)褥期產(chǎn)婦感染的療效和安全性。方法：本文選取了2021年6月—2023年4月住院的24名產(chǎn)婦，采用隨機抽樣方法將其分成兩組，每組12名。對照組采用左氧氟沙星治療，觀察組采用頭孢他啶治療，比較兩組的臨床效果及血象各項指標(biāo)。結(jié)果：治療后，觀察組和對照組的LYM分別為（39.33±4.48）%和（47.45±6.45）%，MON分別為（6.36±1.44）%和（9.14±1.26）%，GRAN分別為（65.89±1.10）%和（77.43±1.63）%，WBC分別為（7.39±1.43）×109/L和（10.26±1.54）×109/L，觀察組血象各項指標(biāo)與臨床療效均優(yōu)于對照組（P

【關(guān)鍵詞】頭孢他啶；產(chǎn)婦；產(chǎn)褥期感染；療效；安全性

Study on the efficacy and safety of ceftazidime in the treatment of puerperal infection in parturients

YANG Yanyan

Chengxian People’s Hospital of Longnan City， Gansu， Longnan， Gansu 742500， China

【Abstract】Objective：To investigate the efficacy and safety of ceftazidime in the treatment of puerperal infection in parturients. Methods：In this study，24 postpartum women hospitalized from June 2021 to April 2023 were selected and divided into two groups using a random sampling method，with 12 women in each group.The control group was treated with levofloxacin，while the observation group was treated with ceftazidime.The clinical effects and various hematological parameters of the two groups were compared.Results：After treatment，the LYM of the observation group and the control group were （39.33±4.48）% and （47.45±6.45）%，the MON were （6.36±1.44）% and （9.14±1.26）%，the GRAN were （65.89±1.10）% and （77.43±1.63）%，and the WBC were （7.39±1.43）×109/L and （10.26±1.54）×109/ L，respectively，and various hematological parameters and clinical efficacy of the observation group were better than those of the control group （P

【Key Words】Ceftazidime； Puerpera； Puerperal infection； Curative effect； Security

產(chǎn)婦在分娩后的產(chǎn)褥期容易發(fā)生感染，常見的感染部位包括子宮、陰道、泌尿道和傷口等。（剩余4037字）